We are live on ! Find out more
SLXNW

Silexion Therapeutics Warrant
SLXNW

25 hedge funds and large institutions have $199K invested in Silexion Therapeutics Warrant in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more capital invested

Capital invested by funds: $91.7K → $199K (+$107K)

0.27% more ownership

Funds ownership: 23.55% → 23.82% (+0.27%)

4% less funds holding

Funds holding: 26 → 25 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
5
Closed
4
Calls
$17K
Puts
–
Net Calls
+$17K
Net Calls Change
-$12K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.15K
2
GCIA
Gabelli & Co Investment Advisers
New York
+$2.32K
3
GF
Gabelli Funds
New York
+$1.86K
4
Goldman Sachs
Goldman Sachs
New York
+$159

Top Sellers

Rank Fund Capital Flow
1
Walleye Trading
Walleye Trading
New York
-$1.19K
2
GS
GTS Securities
New York
-$799
3
Citadel Advisors
Citadel Advisors
Florida
-$456
4
AC
Aristeia Capital
Connecticut
-$343
5
HP
Hartree Partners
New York
-$313
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMP
1
Polar Asset Management Partners
Ontario, Canada
$56.9K – – –
LA
2
Linden Advisors
New York
$23.6K – – –
AC
3
Aristeia Capital
Connecticut
$16.5K -$343 -5,628 -2%
HP
4
Hartree Partners
New York
$14.6K -$313 -5,145 -3%
CS
5
Clear Street
New York
$11.1K -$17 -276 -0.2%
SBLIC
6
Security Benefit Life Insurance Company
Kansas
$10.5K – – –
Goldman Sachs
7
Goldman Sachs
New York
$8.42K +$159 +2,617 +2%
KC
8
Kepos Capital
New York
$8K – – –
PC
9
Periscope Capital
Ontario, Canada
$6.67K – – –
Jane Street
10
Jane Street
New York
$5.76K -$26 -419 -0.6%
YCM
11
Yakira Capital Management
Connecticut
$5.74K – – –
PMAM
12
Picton Mahoney Asset Management
Ontario, Canada
$4K – – –
CCM
13
Context Capital Management
California
$3.92K – – –
TCM
14
Tenor Capital Management
New York
$3.83K – – –
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$3.63K +$3.15K +51,801 New
GCIA
16
Gabelli & Co Investment Advisers
New York
$2.92K +$2.32K +38,150 New
Neuberger Berman Group
17
Neuberger Berman Group
New York
$2.41K – – –
GF
18
Gabelli Funds
New York
$2.33K +$1.86K +30,496 New
DCM
19
Dupont Capital Management
Delaware
$2.28K – – –
MTCM
20
Mint Tower Capital Management
Netherlands
$2K – – –
Stifel Financial
21
Stifel Financial
Missouri
$1.22K – – –
RCM
22
Rivernorth Capital Management
Florida
$1.15K – – –
SCM
23
Saba Capital Management
New York
$835 – – –
CCA
24
Cobblestone Capital Advisors
New York
$765 – – –
Bank of America
25
Bank of America
North Carolina
$8 -$9 -155 -58%
1
2

SLXNW Hedge Fund Activity: Q1 2025 in Review

25 of the 7,462 institutional investors tracked by Wall St. Rank reported a position in Silexion Therapeutics Warrant (SLXNW) for Q1 2025, worth a combined $199K — up 117% from $91.7K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of SLXNW and 3 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 1 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $3.15K. The largest seller was Walleye Trading, exiting entirely with an estimated $1.19K sold.

  • 25 institutional investors held Silexion Therapeutics Warrant (SLXNW) as of Q1 2025, down from 26 in Q4 2024.
  • Funds reported $199K of Silexion Therapeutics Warrant stock for Q1 2025, up 117% quarter-over-quarter.
  • 3 funds opened new Silexion Therapeutics Warrant positions in Q1 2025 and 4 closed out, a net change of -1 holder.
  • The largest Silexion Therapeutics Warrant buyer in Q1 2025 was Susquehanna International Group, an estimated $3.15K added.
  • The largest Silexion Therapeutics Warrant seller in Q1 2025 was Walleye Trading, an estimated $1.19K sold.

Based on aggregated 13F filings for Q1 2025.